NuCana (NuCana) Other Current Liabilities

: $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

NuCana's other current liabilities for the quarter that ended in Dec. 2023 was $0.00 Mil.

NuCana's quarterly other current liabilities declined from Jun. 2023 ($3.79 Mil) to Sep. 2023 ($0.00 Mil) but then from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($0.00 Mil).

NuCana's annual other current liabilities increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($4.99 Mil) but then declined from Dec. 2022 ($4.99 Mil) to Dec. 2023 ($0.00 Mil).

NuCana Other Current Liabilities Historical Data

The historical data trend for NuCana's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NuCana Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

NuCana Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Current Liabilities																-	-	-	-	-

NuCana Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

NuCana Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of NuCana's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

NuCana (NuCana) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NuCana PLC (NAS:NCNA) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

N04A:Germany

Address

3 Lochside Way, Edinburgh, GBR, EH12 9DT

Website

https://www.nucana.com

NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Geographically operates through the region of the United States.